Document is current
Any future updates will be listed below
-
Authors
Popovic, M.
Talarico, O.
van den Hoff, J.
Kunin, H.
Zhang, Z.
Lafontaine, D.
Dogan, S.
Leung, J.
Kaye, E.
Czmielewski, C.
Mayerhoefer, M. E.
Zanzonico, P.
Yaeger, R.
Schöder, H.
Humm, J. L.
Solomon, S. B.
Sofocleous, C. T.
Kirov, A. S. http://orcid.org/0000-0001-6521-3582
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
- License Information
-
More Information
Article History
Received: 30 June 2020
Accepted: 21 September 2020
First Online: 23 November 2020
Ethics approval and consent to participate
: The Institutional Review Board/Privacy Board-B of Memorial Sloan Kettering Cancer Center (IRB) approved the study and waived the need for informed consent. The IRB reviews and oversees human subject research to assure that it meets the ethical principles embodied in the Belmont Report and complies with US federal regulations that pertain to human subject protection at 45 CFR 46 and 21 CFR 50 and 56, AAHRPP standards, and other pertinent regulations, guidance and state and local laws.
: Not applicable. See above.
: The authors declare that they have no competing interests. SBS is a consultant for Varian, Johnson & Johnson, Aperture, XACT Robotics and Endoways, has research support from GE Healthcare, Elesta, Johnson & Johnson and AngioDynamics and is a shareholder in Johnson & Johnson and Aperture. MEM received speaker honoraria from Bristol Myers Squibb and Siemens and research support from Siemens, unrelated to the work considered.
